Earnings History Data for Eiger BioPharmaceuticals, Inc. (EIGR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc. is a biopharmaceutical company which develops and manufactures drugs and therapies for the treatment of orphan diseases. Eiger BioPharmaceuticals, Inc., formerly known as Celladon Corporation, is based in Palo Alto, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
03-11-2022	AH	4:05 PM ET (Nov 3)	EIGR	Eiger BioPharmaceuticals, Inc.	229.07	-0.62	-0.55	-0.65	Eiger BioPharmaceuticals GAAP EPS of -$0.62 misses by $0.10, revenue of $4.02M misses by $0.24M [11/3/2022 4:23 PM]	4.29	-0.36 (-7.63%)	4.50	-0.15 (-3.23%)	3.53 - 10.02	558,315	370,000	2,750
Eiger BioPharmaceuticals GAAP EPS of -$0.62 misses by $0.10, revenue of $4.02M misses by $0.24M [11/3/2022 4:23 PM] Eiger BioPharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update [Nov-03-22 04:01PM] Eiger BioPharmaceuticals (EIGR) Reports Q3 Loss, Tops Revenue Estimates [Nov-03-22 05:55PM]
04-08-2022	AH	4:05 PM ET (Aug 4)	EIGR	Eiger BioPharmaceuticals, Inc.	364.74	-0.51	-0.71	-0.57	Eiger BioPharmaceuticals GAAP EPS of -$0.51 beats by $0.11, revenue of $4.09M misses by $0.99M [8/4/2022 4:36 PM]	8.75	-0.90 (-9.33%)	9.63	-0.02 (-0.21%)	3.53 - 10.02	728,382	230,000	19,908
Eiger BioPharmaceuticals GAAP EPS of -$0.51 beats by $0.11, revenue of $4.09M misses by $0.99M [8/4/2022 4:36 PM] Eiger BioPharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update [Aug-04-22 04:05PM] Eiger BioPharmaceuticals (EIGR) Reports Q2 Loss, Tops Revenue Estimates [Aug-04-22 07:25PM]
05-05-2022	AH	4:00 PM ET (May 5)	EIGR	Eiger BioPharmaceuticals, Inc.	242.48	-0.64	-0.66	-0.49	Eiger BioPharmaceuticals GAAP EPS of -$0.64 in-line, revenue of $2.67M misses by $1.38M [5/5/2022 4:27 PM]	6.39	0.24 (3.90%)	6.36	0.21 (3.41%)	3.53 - 10.02	541,093	370,000	706
Eiger BioPharmaceuticals GAAP EPS of -$0.64 in-line, revenue of $2.67M misses by $1.38M [5/5/2022 4:27 PM] Eiger BioPharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update [May-05-22 04:01PM] Eiger BioPharmaceuticals (EIGR) Reports Q1 Loss, Lags Revenue Estimates [May-05-22 07:25PM]
10-03-2022	AH	4:00 PM ET (Mar 10)	EIGR	Eiger BioPharmaceuticals, Inc.	145.08	-0.64	-0.67	-0.58	Eiger BioPharmaceuticals GAAP EPS of -$0.64 misses by $0.01, revenue of $3.36M misses by $0.03M [3/10/2022 4:03 PM]	5.07	0.65 (14.71%)	4.35	-0.07 (-1.58%)	3.53 - 10.45	406,026	210,000	183,697
Eiger BioPharmaceuticals GAAP EPS of -$0.64 misses by $0.01, revenue of $3.36M misses by $0.03M [3/10/2022 4:03 PM] Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update [Mar-10-22 04:01PM]
04-11-2021	AH	4:00 PM ET (Nov 4)	EIGR	Eiger BioPharmaceuticals, Inc.	239.36	-0.65	-0.58	-0.52	Eiger BioPharmaceuticals EPS misses by $0.09, beats on revenue [11/4/2021 4:42 PM]	8.19	0.24 (3.02%)	7.60	-0.35 (-4.40%)	5.82 - 13.49	303,624	200,000	1,782
Eiger BioPharmaceuticals EPS misses by $0.09, beats on revenue [11/4/2021 4:42 PM] Eiger BioPharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update [Nov-04-21 04:01PM] Eiger BioPharmaceuticals (EIGR) Reports Q3 Loss, Tops Revenue Estimates [Nov-04-21 06:25PM]
05-08-2021	AH	4:00 PM ET (Aug 5)	EIGR	Eiger BioPharmaceuticals, Inc.	270.25	-0.57	-0.54	-0.60	Eiger BioPharmaceuticals EPS misses by $0.02, misses on revenue [8/5/2021 4:19 PM]	8.35	0.12 (1.46%)	7.77	-0.46 (-5.59%)	7.57 - 13.49	143,568	240,000	1,709
Eiger Announces FDA Breakthrough Therapy Designation for Avexitide for Treatment of Congenital Hyperinsulinism [Aug-05-21 08:00AM] Eiger BioPharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update [Aug-05-21 04:01PM] Eiger BioPharmaceuticals (EIGR) Reports Q2 Loss, Tops Revenue Estimates [Aug-05-21 05:55PM]
06-05-2021	AH	4:05 PM ET (May 6)	EIGR	Eiger BioPharmaceuticals, Inc.	294.26	-0.49	-0.51	-0.62	Eiger BioPharmaceuticals EPS beats by $1.09, misses on revenue [5/6/2021 4:33 PM]	8.54	-0.11 (-1.27%)	9.25	0.60 (6.94%)	7.57 - 13.99	196,209	250,000	300
Eiger BioPharmaceuticals EPS beats by $1.09, misses on revenue [5/6/2021 4:33 PM] Eiger BioPharmaceuticals, Inc. to Host Earnings Call [May-06-21 02:45PM] Eiger BioPharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update [May-06-21 04:01PM]
09-03-2021	AH		EIGR	Eiger Biopharmaceuticals, Inc.	295.00	-0.58	0.33	0.00	Eiger BioPharmaceuticals EPS of -$0.58 [3/9/2021 4:38 PM]	9.48	-0.25 (-2.57%)	10.01	0.28 (2.88%)	4.55 - 13.99	206,954	209,263	491
Eiger BioPharmaceuticals EPS of -$0.58 [3/9/2021 4:38 PM] Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update [Mar-09-21 04:05PM] Eiger BioPharmaceuticals (EIGR) Reports Q4 Loss, Lags Revenue Estimates [Mar-09-21 06:25PM]
05-11-2020	AH		EIGR	Eiger BioPharmaceuticals, Inc.	276.35	-0.52	-0.60	-0.76	Eiger BioPharmaceuticals EPS beats by $0.07 [11/5/2020 5:12 PM]	10.33	1.29 (14.32%)	9.30	0.26 (2.88%)	4.55 - 15.82	775,719	384,037	1,791